SCHEMBL6735376

SCHEMBL6735376

O=C(O)c1cc(Cl)c(C(=O)O)c(Cl)c1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
CASP1 P29466 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AKR1C2 P52895 2/20 0.42
AKR1C1 Q04828 2/20 0.42
AKR1C4 P17516 1/20 0.42
AKR1C3 P42330 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP3A4 P08684 1/20 0.41
POLB P06746 3/20 0.40
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11049300 0.88 CYP3A4 (0.45) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL543424 0.86 CYP3A4 (0.45) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL3136996 0.86 TSHR (0.43) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL11727816 0.85 DPP4 (0.46) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL7738805 0.84 ALDH1A1 (0.45) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL705877 0.84 DPP4 (0.35) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL5465587 0.82 CYP3A4 (0.45) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL31194455 0.82 CYP3A4 (0.45) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL11680098 0.81 TSHR (0.39) ALDH1A1TSHRTP53CASP1SMN1; SMN2
SCHEMBL11343587 0.81 ALDH1A1 (0.40) ALDH1A1TSHRTP53CASP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116589475-B Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-09-29 CN claimed
CN-116589475-A Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-08-15 CN claimed
CN-114736213-B Preparation method of carboxyl-tetrachloro-fluorescein 合肥华纳生物医药科技有限公司 2024-02-02 CN disclosed
CN-116589475-B Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-09-29 CN disclosed
CN-116589475-B Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-09-29 CN disclosed
CN-116589475-A Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-08-15 CN disclosed
CN-116589475-A Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-08-15 CN disclosed
CN-114736213-A Preparation method of carboxyl-tetrachloro-fluorescein 合肥华纳生物医药科技有限公司 2022-07-12 CN disclosed
US-6673550-B2 PROBES FOR USE IN THE DETECTION AND MEASUREMENT OF PREFERENTIAL COMPOUND IN SAMPLE ACLARA BIOSCIENCES, INC. 2004-01-06 US disclosed
US-20020146726-A1 Electrophoretic tag reagents comprising fluorescent compounds ACLARA BIOSCIENCES, INC. 2002-10-10 US disclosed
US-20020142329-A1 Compositions and methods employing cleavable electrophoretic tag reagents ACLARA BIOSCIENCES, INC. 2002-10-03 US disclosed
EP-0500779-A4 1994-02-23 EP disclosed
EP-0500779-A1 4,7-DICHLOROFLUORESCEIN DYES AS MOLECULAR PROBES THE PERKIN-ELMER CORPORATION (US) 1992-09-02 EP disclosed
WO-1991007507-A1 4,7-DICHLOROFLUORESCEIN DYES AS MOLECULAR PROBES APPLIED BIOSYSTEMS, INC. (US) 1991-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020142329-A1 Compositions and methods employing cleavable electrophoretic tag reagents ENDOD1, TMPRSS15, ECE1 ALDH1A1 3314/4885TSHR 1470/4885TP53 1732/4885
US-20020146726-A1 Electrophoretic tag reagents comprising fluorescent compounds ENDOD1, ECE1, ELANE ALDH1A1 2656/4885TSHR 1339/4885TP53 623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.